Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christen Shoesmith

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2022
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approachesCorey T McMillan, Joanne Wuu, Katya Rascovsky, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 16, 2018
Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral SclerosisVictoria L Hodgkinson, Josh Lounsberry, Ario Mirian, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 27, 2021
Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practicesKristiana Salmon, Nancy Anoja, Ari Breiner, et al.
Neurology|October 4, 2019
Ventricular volume expansion in presymptomatic genetic frontotemporal dementiaTamara P Tavares, Derek G V Mitchell, Kristy Coleman, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
The CNDR: collaborating to translate new therapies for CanadiansLawrence Korngut, Craig Campbell, Megan Johnston, et al.
Brain : a Journal of Neurology|December 2, 2022
Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriersElizabeth Finger, Rubina Malik, Martina Bocchetta, et al.
The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.
Molecular Genetics & Genomic Medicine|June 6, 2022
Targeted copy number variant identification across the neurodegenerative disease spectrumAllison A Dilliott, Kristina K Zhang, Jian Wang, et al.
Muscle & Nerve|March 2, 2026
Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament AnalysesEric Sorenson, Daragh Heitzman, Ikjae Lee, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 13, 2023
Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with FunctionDaniel Kapustin, Shadi Zarei, Wei Wang, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2022
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approachesCorey T McMillan, Joanne Wuu, Katya Rascovsky, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 16, 2018
Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral SclerosisVictoria L Hodgkinson, Josh Lounsberry, Ario Mirian, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 27, 2021
Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practicesKristiana Salmon, Nancy Anoja, Ari Breiner, et al.
Neurology|October 4, 2019
Ventricular volume expansion in presymptomatic genetic frontotemporal dementiaTamara P Tavares, Derek G V Mitchell, Kristy Coleman, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
The CNDR: collaborating to translate new therapies for CanadiansLawrence Korngut, Craig Campbell, Megan Johnston, et al.
Brain : a Journal of Neurology|December 2, 2022
Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriersElizabeth Finger, Rubina Malik, Martina Bocchetta, et al.
The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.
Molecular Genetics & Genomic Medicine|June 6, 2022
Targeted copy number variant identification across the neurodegenerative disease spectrumAllison A Dilliott, Kristina K Zhang, Jian Wang, et al.
Muscle & Nerve|March 2, 2026
Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament AnalysesEric Sorenson, Daragh Heitzman, Ikjae Lee, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 13, 2023
Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with FunctionDaniel Kapustin, Shadi Zarei, Wei Wang, et al.
Pageof 6